Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
1H-Indole-3-propanoic acid, 2-carboxy-4,6-dichloro- REF: IN-DA000UY3CAS: 130798-51-5 | 98% | 222.00 € | Thu 05 Dec 24 | |
MDL 29951 REF: TR-M199790CAS: 130798-51-5 | - - - | 260.00 €~1,749.00 € | Wed 15 Jan 25 | |
MDL-29951 REF: 3D-FFA79851CAS: 130798-51-5 | Min. 95% | 128.00 €~2,806.00 € | Thu 16 Jan 25 | |
MDL-29951 REF: TM-T1897CAS: 130798-51-5 | 99.07% - 99.49% | 50.00 €~837.00 € | Thu 23 Jan 25 | |
MDL 29951 REF: 10-F468341CAS: 130798-51-5 | 98% | - - - | Discontinued product |
1H-Indole-3-propanoic acid, 2-carboxy-4,6-dichloro-
CAS:130798-51-5
Formula:
C12H9Cl2NO4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
302.1102
Ref: IN-DA000UY3
10mg | 222.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
MDL 29951
Controlled ProductCAS:130798-51-5
Applications MDL 29951 is an allosteric inhibitor of the enzyme fructose 1,6-bisphosphatase. References Wright, S., …
Formula:
C12H9Cl2NO4
Color and Shape:
Neat
Molecular weight:
302.11
Ref: TR-M199790
25mg | 260.00 € | ||
250mg | 1,749.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
MDL-29951
CAS:130798-51-5
MDL-29951 is a drug that acts as a glycogen synthase kinase-3 inhibitor. It is being …
Formula:
C12H9Cl2NO4
Purity:
Min. 95%
Molecular weight:
302.11 g/mol
Ref: 3D-FFA79851
25mg | 935.00 € | ||
50mg | 1,275.00 € | ||
100mg | 1,913.00 € | ||
250mg | 2,806.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
MDL-29951
CAS:130798-51-5
MDL-29951 is a novel glycine antagonist of NMDA receptor activation.
Formula:
C12H9Cl2NO4
Purity:
99.07% - 99.49%
Color and Shape:
Solid
Molecular weight:
302.11
Ref: TM-T1897
1mg | 50.00 € | ||
5mg | 101.00 € | ||
10mg | 174.00 € | ||
25mg | 315.00 € | ||
50mg | 452.00 € | ||
100mg | 621.00 € | ||
200mg | 837.00 € | ||
1mL*10mM (DMSO) | 105.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025
Ref: 10-F468341
250mg | Discontinued | Request information |